Until a couple of years ago, one would be hard-pressed to find someone who was familiar with a pharmaceutical product used to treat moderate-to-severe eczema.
Thanks to spot television, the brand awareness level of Dupixent is likely much higher than it would be otherwise.
It is the Sanofi-owned brand’s use of spot TV and its commitment to the media that has likely fueled Dupixent’s rise in the U.S.
And, for the week ending October 23, Dupixent was the No. 1 brand using Spot TV, according to Media Monitors. Some 27,343 spots were attributed to Media Monitors.
That’s not the only pharmaceutical brand using Spot TV to win over users.
RINVOQ, used to treat ulcerative colitis and rheumatoid arthritis, is the No. 4 brand at Spot TV for the week, with some 20,271 spots.
Other notable activity includes Verizon Wireless, Amazon.com, and Vicks.
How does the Spot Ten Cable report compare?
Here, Progressive has much more in-category competition, with GEICO and Liberty Mutual Insurance in the mix.
Promotion for the film “Black Adam” was heavy, while a new effort from IHOP pushed the fast-casual chain into the Spot Ten Cable report.
